Ellen V. Chiniara's Insider Trades & SAST Disclosures
Ellen V. Chiniara's most recent trade in Kymera Therapeutics Inc was a trade of 55,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ellen V. Chiniara.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kymera Therapeutics Inc | Ellen V. Chiniara | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Ellen V. Chiniara | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 27,500 | 82,326 | - | 0 | Common Stock | |
| Kymera Therapeutics Inc | Ellen V. Chiniara | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 30.33 per share. | 03 Mar 2025 | 1,833 | 80,493 | - | 30.3 | 55,590 | Common Stock |
| Kymera Therapeutics Inc | Ellen V. Chiniara | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 31.00 per share. | 03 Mar 2025 | 408 | 80,085 | - | 31.0 | 12,650 | Common Stock |
| Compass Therapeutics Inc | Ellen V. Chiniara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Ellen V. Chiniara | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 41.75 per share. | 06 Jan 2025 | 3,129 | 54,826 | - | 41.8 | 130,645 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges